The Skipton Fund Appeals Panel was chaired by Mark Mildred who was an experienced solicitor who had previously been involved in the litigation brought by people with haemophilia who had contracted HIV, and had informally advised the claimants' legal teams in litigation concerning Hepatitis C and variant Creutzfeldt-Jakob disease.